Related Articles
Therapeutic options in patients with biochemical recurrence after radical prostatectomy (Review)
Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer
A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer